- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/6883 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Patent holdings for IPC class C12Q 1/6883
Total number of patents in this class: 7744
10-year publication summary
|
224
|
289
|
596
|
735
|
754
|
730
|
782
|
797
|
741
|
703
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4444 |
173 |
| The Regents of the University of California | 20289 |
136 |
| Natera, Inc. | 329 |
133 |
| The Board of Trustees of the Leland Stanford Junior University | 6535 |
98 |
| Cedars-Sinai Medical Center | 1176 |
79 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3373 |
68 |
| The Johns Hopkins University | 5751 |
65 |
| The Children's Hospital of Philadelphia | 810 |
59 |
| The General Hospital Corporation | 4797 |
56 |
| The Brigham and Women's Hospital, Inc. | 2226 |
50 |
| The Chinese University of Hong Kong | 155 |
48 |
| Centre National de La Recherche Scientifique | 10693 |
45 |
| The Broad Institute, Inc. | 1870 |
45 |
| President and Fellows of Harvard College | 6036 |
44 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2991 |
44 |
| Yale University | 2444 |
41 |
| Duke University | 3107 |
38 |
| Children's Hospital Medical Center | 736 |
35 |
| bioMerieux | 921 |
34 |
| Assistance Publique-hopitaux de Paris (aphp) | 532 |
33 |
| Other owners | 6420 |